title: Terminal deoxynucleotidyltransferase distribution in neoplastic and hematopoietic cells.
abstract: In the present study, terminal deoxynucleotidyltransferase was examined in the peripheral blood and (or) bone marrow of 115 children with a variety of neoplastic, hematologic, and other unrelated disorders. Terminal deoxynucleotidyltransferase activity was present at 4.08+/-0.74 U/108 cells in 23 morphologicall normal bone marrow samples from childhood controls. Terminal transferase was present at greater than 23 U/108 nucleated cells and at greater than31 U/108 blasts in the bone marrow of all children with acute lymphoblastic leukemia studied at initial diagnosis and at disease relapse. Terminal deoxynucleotidyltransferase was detectable at low levels, less than 7.5 U/108 cells, in all remission marrow smaples. Bone marrow terminal transferase activity was markedly elevated in all untreated acute lymphoblastic leukemia patients, whereas low levels which were difficult to interpret were present in the peripheral blood samples of two patients at diagnosis and six patients at relapse who had low absolute lymphoblast counts. Because of greater variation in the lymphoblast content of peripheral blood, bone marrow assays are more reliable in detecting disease activity. Marrow terminal deoxynucleotidyltransferase values obtained during the active phase of acute lymphoblastic leukemia were significantly greater than those found in other types of leukemia, bone marrow malignancies, and hematologic disorders. Terminal transferase determinations in blast cells of two patients with leukemic conversion of non-Hodgkin's lymphoma and in tumor cells from one patient with Burkitt's lymphoma were within the control range. These dat further define the usefulness of terminal deoxynucleotidyltrnasferase assay in the differentiation and classication of hematologic malignancies.
mesh_terms: D000293:Adolescent; D000741:Anemia, Aplastic / Q000201:enzymology; D001853:Bone Marrow / Q000201:enzymology*; D001854:Bone Marrow Cells; D002648:Child; D002675:Child, Preschool; D004254:DNA Nucleotidyltransferases / Q000032:analysis* / Q000097:blood; D006801:Humans; D007945:Leukemia, Lymphoid / Q000201:enzymology*; D015470:Leukemia, Myeloid, Acute / Q000201:enzymology; D008214:Lymphocytes / Q000201:enzymology*; D008223:Lymphoma / Q000201:enzymology; D009369:Neoplasms / Q000201:enzymology*; D009447:Neuroblastoma / Q000201:enzymology; D009841:Oligonucleotides; D011696:Purpura, Thrombocytopenic / Q000201:enzymology; D012008:Recurrence; D012075:Remission, Spontaneous; D012208:Rhabdomyosarcoma / Q000201:enzymology
chemical_list: D009841:Oligonucleotides; D004254:DNA Nucleotidyltransferases
references.citation: Br J Haematol. 1976 Nov;34(3):447-56
references.pmid: 62584
references.citation: Scand J Clin Lab Invest Suppl. 1968;97:77-89
references.pmid: 4179068
references.citation: Nature. 1974 Mar 29;248(447):409-11
references.pmid: 4545077
references.citation: Biochem Biophys Res Commun. 1971 Jul 2;44(1):124-31
references.pmid: 4330042
references.citation: Proc Natl Acad Sci U S A. 1973 Feb;70(2):521-5
references.pmid: 4346893
references.citation: Biochem Biophys Res Commun. 1973 Apr 2;51(3):529-35
references.pmid: 4512981
references.citation: Immunology. 1970 Oct;19(4):637-50
references.pmid: 4097588
references.citation: N Engl J Med. 1976 Jan 29;294(5):245-8
references.pmid: 53789
references.citation: Lancet. 1976 Mar 6;1(7958):508-9
references.pmid: 55782
references.citation: J Clin Invest. 1973 Apr;52(4):919-28
references.pmid: 4571426
references.citation: Br Med J. 1974 Jun 22;2(5920):643-6
references.pmid: 4546214
references.citation: Clin Immunol Immunopathol. 1973 Jul;1(4):511-22
references.pmid: 4549205
references.citation: Biochem Biophys Res Commun. 1975 Jul 22;65(2):673-82
references.pmid: 238537
references.citation: J Biol Chem. 1974 Dec 25;249(24):8051-3
references.pmid: 4529878
references.citation: Proc Natl Acad Sci U S A. 1974 Nov;71(11):4404-8
references.pmid: 4530991
references.citation: Proc Natl Acad Sci U S A. 1975 Oct;72(10):4119-22
references.pmid: 812089
references.citation: N Engl J Med. 1975 Apr 17;292(16):828-32
references.pmid: 1078713
references.citation: Blood. 1976 Jan;47(1):11-20
references.pmid: 1081893
references.citation: Cancer Res. 1976 Jan;36(1):120-7
references.pmid: 1061638
references.citation: N Engl J Med. 1975 Apr 10;292(15):775-80
references.pmid: 1054106
references.citation: Biochem Biophys Res Commun. 1975 Jan 20;62(2):367-75
references.pmid: 1053892
references.citation: J Biol Chem. 1976 Apr 25;251(8):2399-404
references.pmid: 1262329
references.citation: Science. 1975 Oct 17;190(4211):284-5
references.pmid: 1179209
references.citation: Res Commun Chem Pathol Pharmacol. 1975 Apr;10(4):715-24
references.pmid: 1153847
references.citation: J Exp Med. 1975 Apr 1;141(4):855-65
references.pmid: 1127379
references.citation: J Biol Chem. 1971 Feb 25;246(4):909-16
references.pmid: 5543689
references.citation: Biochemistry. 1971 Feb 2;10(3):536-42
references.pmid: 5543985